United States · Bill · HR
H.R. 6888 (117th)
Helping Experts Accelerate Rare Treatments Act of 2022
Introduced
1 March 2022
Last action
2 March 2022 · Referred
Status
Referred to the Subcommittee on Health.
Sponsors
Rep. Tonko, Paul [D-NY-20], Rep. McKinley, David B. [R-WV-1]
Subjects
Healthcare
Source updated
7 April 2025
Summary
Helping Experts Accelerate Rare Treatments Act of 2022 This bill requires studies on processes for approving drugs that treat rare diseases and conditions. The Government Accountability Office (GAO) must contract with an appropriate entity to study the European Union's process for evaluating the safety and efficacy of such drugs, including any flexibilities or mechanisms that are specific to rare diseases or conditions. The GAO must also conduct a study about the Food and Drug Administration's mechanisms for ensuring that patient and physician perspectives are considered when evaluating and approving drugs for rare diseases or conditions. The GAO must report to Congress the results of these studies.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
1 March 2022
Introduced
Referred to the House Committee on Energy and Commerce.
Source: IntroReferral
1 March 2022
Introduced
Introduced in House
Source: IntroReferral
1 March 2022
Introduced
Introduced in House
Source: IntroReferral
2 March 2022
Referred
Referred to the Subcommittee on Health.
Source: Committee
Votes
No vote records are attached yet.
Versions
- Introduced in House · 1 March 2022 · Download file
Documents
3 official files
Introduced in House (text)
This file cannot be previewed here. Use View or Download.
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House (text)
Introduced in House · EN · 1 March 2022
Introduced in House (PDF)
Introduced in House · EN · 1 March 2022
ViewDownloadOpen at official source
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Introduced in House
summary · EN · 1 March 2022
Leesvertaling
Vertaal dit document naar jouw taal. PoliticalRepo bewaart geen aparte kopie per EU-taal.
Documentvertaling op verzoek met downloadbare PDF (logo + link naar de officiële bron). Het bronbestand blijft leidend.
Sponsors
- Rep. Tonko, Paul [D-NY-20] · D · Sponsor
- Rep. McKinley, David B. [R-WV-1] · R · Sponsor
- · hsif00 · Standing
Related records
- related to ← Food and Drug Amendments of 2022
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/117th-congress/house-bill/6888
- Open data entity: https://api.congress.gov/v3/bill/117/hr/6888
- us · 117-hr-6888 · source updated 7 April 2025